Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses 105 M103 M105 M — Research & development 182 M57 M53 M — Operating income 1.08 B1.04 B1.32 B — Non-Operating Income, Total -412 M-447 M-683 M — Interest expense, net of interest capitalized 287 M328 M453 M — Non-Operating Income, excl. Interest Expenses -699 M-775 M-1.14 B — Unusual income/expense ——— — Pretax income 668 M591 M637 M — Equity in earnings ——— — Taxes 151 M116 M87 M — Non-controlling/minority interest 53 M40 M54 M — After tax other income/expense -41 M-40 M-20 M — Net income before discontinued operations 464 M435 M496 M — Discontinued operations ——— — Net income 464 M435 M496 M — Dilution adjustment 000 — Preferred dividends 68 M67 M67 M — Diluted net income available to common stockholders 396 M368 M429 M — Basic earnings per share (Basic EPS) 0.170.150.17 — Diluted earnings per share (Diluted EPS) 0.150.140.16 — Average basic shares outstanding 2.4 B2.41 B2.42 B — Diluted shares outstanding 2.64 B2.64 B2.64 B — EBITDA 1.94 B2.02 B2.34 B — EBIT 1.73 B1.75 B2.12 B — Cost of revenue 1.06 B1.42 B1.39 B — Other cost of goods sold 1.06 B1.42 B1.39 B — Depreciation & amortization (cash flow) 216 M267 M218 M —